Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (229)

« Back to Publications

Public (un)willingness to trade-off benefits and harms in decisions about cancer screening: A discrete choice experiment.

Dennison RA. et al, (2026), J Med Screen

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.

McGeagh L. et al, (2026), Eur J Oncol Nurs, 80

Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK.

Costello RE. et al, (2026), Rheumatology (Oxford), 65

Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma.

Majorova D. et al, (2026), Radiother Oncol, 214

Correction: Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England.

Buckell J. et al, (2026), Br J Cancer, 134, 175 - 176

Evaluating a Clinical Decision Support Tool for Cancer Risk Assessment in Primary Care: Simulation Study of Unintended Weight Loss.

Martinez-Gutierrez J. et al, (2025), JMIR Form Res, 9

Is now the time to rethink risk thresholds in cancer referral guidelines?

Nicholson BD. et al, (2025), Br J Gen Pract, 75, 543 - 544

Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): external validation of colorectal cancer prediction models in English primary care

Virdee PS. et al, (2025)

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

McGeagh L. et al, (2025), Trials, 26

Prostate specific antigen retesting intervals and trends in England: population based cohort study.

Collins KK. et al, (2025), BMJ, 391

Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK.

Byrne RL. et al, (2025), Microbiol Spectr, 13

Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reports.

Tamm A. et al, (2025), BMJ Health Care Inform, 32

Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals.

Collins KK. et al, (2025), BJU Int, 136, 372 - 384

Patient characteristics, serious disease diagnoses, and incidental findings in individuals with non-specific symptoms referred to the Suspected CANcer (SCAN) Pathway: a prospective cohort study in England

Friedemann Smith C. et al, (2025), The Lancet Primary Care, 1, 100019 - 100019

External validation of the COLOFIT colorectal cancer risk prediction model in the Oxford-FIT dataset: the importance of population characteristics and clinically relevant evaluation metrics.

Tamm A. et al, (2025), BMC Med, 23

Load More

1
2
3
4
5
6
7
...
»